Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 50 for “"sST2"”.
-
STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF DEUBIQUITINATING ENZYMES, SST2 AND SSEL
Associated molecule with SH3 domain of molecule (STAM), or AMSH, is a
-
Papel de nuevos biomarcadores en hipertensión pulmonar SST2 y CA-125
… unida a la membrana (ST2L) y una forma soluble (sST2), generada a través de un proceso de splicing. Se ha demostrado que la determinación de la concentración sérica de sST2 es útil para estratificar el riesgo de insuficiencia cardíaca. Los niveles séricos de sST2 están aumentados en los pacientes …
-
sST2 as a candidate for dual biosensing with cTnI in presentations of myocardial infarction
sST2 is an emerging biomarker of interest for cardiovascular stress, where this thesis aims to isolate specific pathologies contributing to its serous release. On a molecular level, sST2 is a decoy receptor that intercepts IL-33 and sequesters its natural association with the transmembrane isoform …
-
Somatostatin Receptor 2 Regulation By C-Terminal Motifs and Pdz Domain Proteins
Somatostatin receptor 2 (sst2) is a Gi-coupled G-protein coupled receptor that mediates many of somatostatin’s neuroendocrine actions. Sst2 is a clinically important GPCR as it is the drug target of somatostatin analogs such as octreotide, lanreotide, and pasireotide. Treatment with these agonists …
-
RUOLO DELLA FILAMINA A NELLA REGOLAZIONE DELL'ESPRESSIONE E DELLA TRADUZIONE DEL SEGNALE DEL RECETTORE DELLA SOMATOSTATINA SST2 IN CELLULE TUMORALI GH-SECERNENTI
… which binding to specific receptor subtypes (SST2, SST5) coupled to inhibitory G proteins, reducing tumor growth and hormonal secretion. SST- mediated signaling involves the inhibition of adenylate cyclase and the activation of K+ channels and closing of channels to the voltage-dependent Ca++, …
-
Συσχέτιση βιοδεικτών καρδιακής ανεπάρκειας με τη λειτουργικότητα των αγγείων και τη νεφρική λειτουργία σε ασθενείς με καρδιακή ανεπάρκεια
… baseline demographic characteristics, levels of sST2 were increased in HF compared to the control (15.8 (11.0, 21.8) ng/mL vs. 12.5 (10.4, 16.3) ng/mL; p < 0.001). In the HF group, there was a positive correlation of sST2 levels with age (rho = 0.22; p = 0.007) while there was no association of …
-
The role of IL-33 and ST2 in early pregnancy
… receptor (ST2L) and a soluble decoy receptor (sST2). Previous work in this laboratory had shown that the human placenta expresses both IL-33 and sST2 at term. The aim of this thesis was to investigate IL-33 and ST2 in early pregnancy, the time when trophoblast is at its most active, with a view …
-
Ανάπτυξη και αξιολόγηση ραδιοεπισημασμένων συνθετικών αναλόγων της σωματοστατίνης για την in vivo εντόπιση νεοπλασμάτων
… of somatostatin receptor subtype 2 (sst2) in many neoplasms of mainly neuroendocrine origin has resulted in an established method for the in vivo diagnostic imaging of sst2-positive tumors using OctreoScan® ([111Ιn-DTPA0]octreotide). Despite its initial success, OctreoScan®’s broader …
-
Prognostische Wertigkeit von löslichem ST2 bei Patient*innen mit akuter Herzinsuffizienz
… Lösliches Suppression of Tumorigenicity 2 (sST2) zeigte sich in bisherigen Studien als potentieller Prädiktor der Kurzzeitmortalität, wobei eine abschließende Beurteilung aufgrund fehlender Daten derzeit nicht möglich ist. Methodik: In der internistischen Notaufnahme des Campus …
-
Μελέτη του ρόλου της σωματοστατίνης και κορτιστατίνης στον αμφιβληστροειδή και στην ισχαιμική αμφιβληστροειδοπάθεια
… posed: to study the functional role of sst1 and sst2 somatostatin receptors, to establish a retinal model of ischemia, to ascertain the neuroprotective actions of SRIF and its analogues in this model, and to elucidate the mechanism involved in the neuroprotection. The results of this thesis …
-
In vivo μελέτη της νευροπροστατευτικής δράσης της σωματοστατίνης στην αμφιβληστροειδική διεγερτοτοξικότητα
… Somatostatin levels and the expression of the sst2 and sst5 somatostatin receptor subtypes were not affected by the AMPA treatment. Intravitreal co-injection of AMPA with somatostatin or sst2 and sst5 selective analogs protected the retina from the AMPA induced toxicity in a dose dependent …
-
Ο ρόλος των βιοδεικτών στην καρδιακή ανεπάρκεια με διατηρημένο κλάσμα εξώθησης - Συστηματική ανασκόπηση
… η χρήση νεότερων βιοδεικτών και συγκεκριμένα των sST2, Gal-3, GDF-15, καθώς φαίνεται να συσχετίζονται με την παθολογική φυσιολογία και τη φυσική πορεία της νόσου. Σκοπός Η συστηματική αυτή ανασκόπηση σκοπεύει να διερευνήσει το διαγνωστικό ή και προγνωστικό ρόλο των sST2, GDF-15 και Gal-3 σε …
-
Προσδιορισμός της συγκέντρωσης των αλαρμινών HMGB1 και IL33 καθώς και των υποδοχέων τους sRAGEs και sST2 αντίστοιχα, στο πλευριτικό υγρό ασθενών με υπεζωκοτική συλλογή ποικίλης αιτιολογίας
… IL-33, HMGB1 and soluble forms of the receptors (sST2 and sRAGE, respectively) have been implicated in several pulmonary diseases. Both axes have been scarcely investigated in pleural diseases. The aims of this thesis were to determine the levels of IL-33 and sST2 as well as ΗΜGB1 and sRAGE in …
-
Immune modulation in normal and pathological human pregnancy
… not change over the course of pregnancy but that sST2 (the soluble decoy receptor) increased significantly in the 3rd trimester of normal pregnancy. Both IL-33 and ST2 were variably expressed by the pre-implantation human blastocyst, as well as by the 1st and 3rd trimester placenta.</p><p>Finally, …
-
IL-13 controls IL-33 activity through modulation of ST2
… ST2L can be inhibited by soluble ST2 (sST2), which acts as a decoy receptor. Previous findings suggested that modulation of IL-13 levels in mice lacking decoy IL-13Rα2, or mice lacking IL-13, impacted responsiveness to IL-33. In this study, we used Il13-/- mice to investigate whether …
-
Ραδιοεπισημασμένα ανάλογα σωματοστατίνης με διευρυμένο φάσμα κλινικών ενδείξεων στην διαγνωστική ογκολογία: ραδιοσημασμένες πανσωματοστατίνες
… stabilized radiopeptide with high affinity to sst2 and high sst2-mediated internalization into target-cells. Today this radiopharmaceutical is the agent of choice for the diagnostic imaging of NETs expressing the sst2 in high density.The above five sst1-5 are expressed concomitantly and in …
-
ST2/MYD88 signaling is a therapeutic target alleviating murine acute graft-versus-host disease sparing T regulatory cell function
… Plasma levels of soluble serum stimulation-2 (sST2) are elevated during human and murine aGVHD and are correlated to a type 1 T cell response. Membrane-bound ST2 (ST2) on donor T cells has been shown to be protective against aGVHD. ST2 signals through the adapter protein myeloid differentiation …
-
Biologische Variabilität von Biomarkern der Herzinsuffizienz
… Methods: The biomarkers NT-proBNP, Galectin-3, sST2, hsTnT, Copeptin and NGAL were quantified twice in between one week in clinical stable patients with HFrEF, HFpEF, aHt and DN. The intraindividual coefficient of variation (CVi = BV) and the reference change value (RCV) were calculated …
-
Διερεύνηση βιοδεικτών επί των ασθενών με καρδιακή ανεπάρκεια
… (CysC), soluble suppression of tumorgenicity 2 (sST2), growth-differentiation factor-15 (GDF-15), prolactin, osteopontin, interleukin-1β and high sensitivity C-reactive protein. Moreover, the prognostic value of simple BMRs, such as uric acid, lipoproteins, and free triiodothyronine (fT3) was …
-
IL-33 and ST2 in innate and adaptive airway inflammation
… ECs may have in Th2 diseases. Soluble ST2 (sST2) has emerged as a biomarker correlating with disease activity in cardiovascular disease. It is not known if there is a clear association between sST2 and asthma, nor whether measurable IL-33 concentrations are present and if so, their …
Page 1 of 3